Marketwatch This pharma stock defies consensus downgrades, risk alerts to keep rising Admin June 5, 2020 This drugmaker reported a consolidated net profit of Rs 314 crore for March quarter. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
